Diamines & Chemicals Ltd. (DIAMINESQ) AI Stock Analysis

• Market Cap: ₹2.18B
• Dividend Yield: 0.38%
• Average Volume (3M): 948.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.00
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: 151
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): -3.48
• Shares Outstanding: 9,783,990
• 10 Day Avg. Volume: 829
• 30 Day Avg. Volume: 948
• PEG Ratio: -1.45
• Price to Book (P/B): 2.03
• Price to Sales (P/S): 4.58
• P/FCF Ratio: -36.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: ₹218.00 ▼(-16.97% Downside)
• Action: N/A Date: 01/04/26
• Date: Action: N/A 01/04/26

The score is primarily held back by weak FY2025 financial performance—sharp margin compression and negative operating/free cash flow—despite a very conservative, low-debt balance sheet. Technicals also remain bearish (below key moving averages with negative MACD), and valuation support is limited given a negative P/E and a very low dividend yield.

Positive Factors

Conservative balance sheet

Near-zero leverage provides durable financial flexibility: it lowers default risk, preserves borrowing capacity, and lets management fund working-capital swings, capex or strategic moves without forcing asset sales. This structural strength cushions downturns and supports long-term resilience.

Multi-year positive cash flow history

A track record of positive operating and free cash flow in prior cycles shows the business can generate cash when conditions normalize. That historical cash-generation ability supports reinvestment, dividends or deleveraging in multi-month horizons if margins and working capital recover.

High gross margin potential

Sizable gross margins indicate either favorable product mix or cost positioning that can absorb input volatility. If management restores operating discipline, the high gross margin base supports recovery in operating margins and durable profitability over a 2–6 month horizon as volumes improve.

Negative Factors

Severe EBIT margin decline

A large, rapid drop in operating margin signals structural pressure on operating leverage—higher fixed costs, pricing erosion or mix shift. Sustained lower EBIT margins reduce internal cash generation and the firm's ability to fund growth or return capital absent clear cost or pricing fixes.

Negative operating and free cash flow

Negative OCF and FCF materially weaken liquidity and constrain capital allocation. Even with low leverage, persistent cash outflows force reliance on equity or asset sales for funding, reducing runway for investments and increasing vulnerability to further demand or working-capital shocks.

Sharp fall in returns (ROE)

A collapse in ROE reflects poor conversion of equity into profit, signaling capital inefficiency. If returns remain depressed, shareholder value creation is impaired and management faces tougher choices on reinvestment, dividends or strategic change to restore profitable growth.

Diamines & Chemicals Ltd. Business Overview & Revenue Model

Company Description

Diamines and Chemicals Limited manufactures and sells organic chemical compounds in India. The company's products include piperazine anhydrous, ethylenediamine, diethylenetriamine, aminoethylpiperazine, triethylenetetramine, tetraethylenepentamine, polyethylene polyamine-mix, monoethanol amine, triethylenediamine, diaminopropane, dipropylene triamine, diacetyl ethylenediamine, tetracetyl ethylenediamine, tetra methyl ethylenediamine, and amine mixture, as well as piperazine derivatives. It exports its chemical products. The company was incorporated in 1976 and is based in Vadodara, India.

How the Company Makes Money

null

Diamines & Chemicals Ltd. Financial Statement Overview

Summary

FY2025 showed a sharp deterioration in operating results and cash conversion: revenue fell (-12.5%), EBIT margin dropped materially (~7.2% vs ~21.7% in FY2024), and both operating cash flow (-50.2m) and free cash flow (-90.4m) turned negative. The balance sheet remains a key strength with near-zero leverage, but returns weakened (ROE ~1.7%), keeping the overall financial profile below average.

Income Statement

Profitability weakened sharply in FY2025: revenue declined (-12.5%) and net margin compressed to ~3.8% (vs ~15.0% in FY2024). While gross margin improved (~49.5% vs ~43.2% last year), operating profitability deteriorated materially (EBIT margin down to ~7.2% vs ~21.7% in FY2024), pointing to higher operating costs and/or weaker operating leverage. Multi-year results show the business can generate strong margins in better cycles (notably FY2020–FY2022), but earnings have been volatile and the recent step-down is a key concern.

Balance Sheet

Balance sheet is very conservatively positioned with near-zero leverage (debt-to-equity ~0.0002 in FY2025) and a steadily growing equity base over time. This low debt load reduces financial risk and gives flexibility through downcycles. The main weakness is the drop in returns: return on equity fell to ~1.7% in FY2025 (from ~10.4% in FY2024), reflecting the sharp decline in profitability rather than balance sheet stress.

Cash Flow

Cash generation weakened significantly in FY2025, with operating cash flow turning negative (-50.2m) and free cash flow also negative (-90.4m), despite positive net income—suggesting working-capital outflows and/or cash conversion pressure. Prior years were generally stronger (positive operating cash flow and free cash flow in FY2024, FY2022, FY2021, FY2020), but the latest year introduces higher cash-flow volatility risk and reduces near-term financial flexibility.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	569.97M	714.72M	1.03B	1.10B	658.90M	626.92M
Gross Profit	259.06M	353.88M	444.26M	737.89M	375.84M	400.07M
EBITDA	-4.46M	86.12M	251.30M	581.54M	237.95M	275.95M
Net Income	-49.48M	27.31M	154.71M	419.04M	167.14M	209.95M
Balance Sheet
Total Assets	1.77B	1.78B	1.63B	1.51B	1.11B	947.79M
Cash, Cash Equivalents and Short-Term Investments	348.36M	413.96M	362.95M	248.05M	390.90M	311.12M
Total Debt	98.15M	251.00K	0.00	0.00	0.00	3.02M
Total Liabilities	232.88M	168.31M	145.62M	165.51M	103.56M	97.92M
Stockholders Equity	1.54B	1.61B	1.48B	1.35B	1.00B	849.87M
Cash Flow
Free Cash Flow	-199.95M	-90.37M	132.88M	-70.06M	123.03M	40.55M
Operating Cash Flow	-71.15M	-50.22M	218.96M	162.85M	272.74M	153.66M
Investing Cash Flow	-108.41M	146.54M	-188.33M	-86.63M	-214.91M	-149.27M
Financing Cash Flow	87.33M	97.47M	-31.29M	-60.15M	-52.80M	-36.86M

Diamines & Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INDOAMIN	63 Neutral	₹6.76B	19.71	―	0.38%	13.01%	32.44%
INDOBORAX	63 Neutral	₹7.82B	24.50	―	0.38%	12.35%	6.79%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DMCC	61 Neutral	₹5.49B	25.70	―	0.97%	40.79%	109.95%
LORDSCHLO	54 Neutral	₹2.87B	23.33	―	―	39.31%	―
KANORICHEM	45 Neutral	₹2.68B	23.83	―	―	-1.30%	-27.85%
DIAMINESQ	43 Neutral	₹2.18B	-19.09	―	0.38%	―	―